James Merselis
Chief Executive Officer at Biosensia Ltd.
Profile
James D.
Merselis is the founder of Synchrony Bio, LLC, which was founded in 2018.
He is currently the Managing Director at Synchrony Bio, LLC.
Mr. Merselis is also currently the Chief Executive Officer & Non-Executive Director at Biosensia Ltd.
since 2012, the Chairman at Kypha, Inc. since 2015, the Chairman at Abram Scientific, Inc. since 2013, the Director at Cardiac Designs, Inc., and the Non-Executive Director at Geneoscopy, Inc. since 2018.
In his former positions, Mr. Merselis served as the President & Chief Executive Officer at Micronics, Inc., the President & Chief Executive Officer at HemoSense, Inc. from 2002 to 2007, the President & Chief Executive Officer at Nexus Dx, Inc., an Independent Non-Executive Director at Trinity Biotech Plc, a Director at Chembio Diagnostics, Inc., a Director at ITC Nexus Holding Co., Inc., and the President at Alverix, Inc. from 2010 to 2011.
Mr. Merselis obtained his undergraduate degree from Nebraska Wesleyan University.
James Merselis active positions
| Companies | Position | Start |
|---|---|---|
Biosensia Ltd.
 Biosensia Ltd. Packaged SoftwareTechnology Services Biosensia Ltd. develops multiplexing point of care in vitro diagnostics platform. It offers RapiPlex, a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results. The company was founded by Gareth Redmond and Gabriel Crean in 2009 and is headquartered in Dublin, Ireland. | Chief Executive Officer | 01/01/2012 |
Abram Scientific, Inc.
 Abram Scientific, Inc. Medical SpecialtiesHealth Technology Abram Scientific, Inc. manufactures medical diagnostic devices. The private company is based in Menlo Park, CA. The company was founded by Abhishek Ramkumar. Edward F. Brennan has been the CEO of the company since 2015. | Chairman | 01/01/2013 |
| Cardiac Designs, Inc. | Director/Board Member | - |
Kypha, Inc.
 Kypha, Inc. Medical/Nursing ServicesHealth Services Kypha, Inc. engages in the development of devices and products to monitor and treat inflammatory and autoimmune disorders. Its products include Comp act, RapiPlex, and sample stabilization. The company was founded by Paul K. Olson and Chad M. Stiening on January 14, 2011 and is headquartered in St. Louis, MO. | Chairman | 01/01/2016 |
Synchrony Bio, LLC
 Synchrony Bio, LLC Financial ConglomeratesFinance Synchrony Bio LLC is a biomedical and life science venture capital firm that aims to achieve superior investor returns in early-stage ventures. The private company is based in St. Louis. The American company aligns seasoned talent, staged investment capital, and process efficiencies to overcome unique challenges faced by medical device and diagnostics ventures, in order to realize significant upside and superior returns. Synchrony Bio's extended network of experts and advisors includes professionals with deep, cross-functional experience and backgrounds. The company was founded by James D. Merselis. | Chief Executive Officer | 01/03/2018 |
Geneoscopy, Inc.
 Geneoscopy, Inc. Miscellaneous Commercial ServicesCommercial Services Geneoscopy LLC develops diagnostics It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. The firm provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. The company was founded by Andrew Barnell, Erica Barnell and Yiming Kang in 2015 and is headquartered in Saint Louis, MO. | Director/Board Member | 01/01/2018 |
Former positions of James Merselis
| Companies | Position | End |
|---|---|---|
ITC Nexus Holding Co., Inc.
 ITC Nexus Holding Co., Inc. Medical SpecialtiesHealth Technology ITC Nexus Holding Co., Inc. is a hospital-focused point-of-care (POC) cardiovascular diagnostics company. It is primarily focused on the manufacture and sale of testing equipment and associated disposables used to measure blood coagulation and platelet response. The company’s two lead products are the Hemochron and VerifyNow systems. Hemochron is used by physicians during cardiovascular interventions to monitor a patient’s blood clotting factors. VerifyNow is used to measure platelet reactivity following antiplatelet therapies, including ADP receptor antagonists and aspirin. | Director/Board Member | 21/05/2014 |
| CHEMBIO DIAGNOSTICS, INC. | Director/Board Member | 09/02/2009 |
HemoSense, Inc.
 HemoSense, Inc. Medical SpecialtiesHealth Technology HemoSense, Inc. develops and manufactures easy-to-use, handheld blood coagulation systems for use by patients and healthcare professionals in the management of warfarin medication. The company was founded in 1997 and is headquartered in San Jose, CA. | Chief Executive Officer | 01/01/2007 |
| ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░ ░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Training of James Merselis
| Nebraska Wesleyan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TRINITY BIOTECH PLC | Health Technology |
| Private companies | 12 |
|---|---|
Chembio Diagnostics, Inc.
 Chembio Diagnostics, Inc. Medical SpecialtiesHealth Technology Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY. | Health Technology |
Micronics, Inc.
 Micronics, Inc. Medical SpecialtiesHealth Technology Micronics, Inc. develops molecular and immuno-hematology diagnostic products. Its products include PanNAT molecular diagnostic system, immunohematology diagnostic products and research & development products. The company was founded in 1996 and is headquartered in Redmond, WA. | Health Technology |
HemoSense, Inc.
HemoSense, Inc. Medical SpecialtiesHealth Technology HemoSense, Inc. develops and manufactures easy-to-use, handheld blood coagulation systems for use by patients and healthcare professionals in the management of warfarin medication. The company was founded in 1997 and is headquartered in San Jose, CA. | Health Technology |
Nexus Dx, Inc.
 Nexus Dx, Inc. Medical/Nursing ServicesHealth Services Nexus Dx, Inc. engages in the provision of of a near patient testing system and advanced diagnostic solution. Its offers point-of-care (POC) immunoassay, IB10 analyzer system, and tests for established critical care parameters. The company was founded on January 16, 2009 and is headquartered in San Diego, CA. | Health Services |
ITC Nexus Holding Co., Inc.
ITC Nexus Holding Co., Inc. Medical SpecialtiesHealth Technology ITC Nexus Holding Co., Inc. is a hospital-focused point-of-care (POC) cardiovascular diagnostics company. It is primarily focused on the manufacture and sale of testing equipment and associated disposables used to measure blood coagulation and platelet response. The company’s two lead products are the Hemochron and VerifyNow systems. Hemochron is used by physicians during cardiovascular interventions to monitor a patient’s blood clotting factors. VerifyNow is used to measure platelet reactivity following antiplatelet therapies, including ADP receptor antagonists and aspirin. | Health Technology |
Kypha, Inc.
Kypha, Inc. Medical/Nursing ServicesHealth Services Kypha, Inc. engages in the development of devices and products to monitor and treat inflammatory and autoimmune disorders. Its products include Comp act, RapiPlex, and sample stabilization. The company was founded by Paul K. Olson and Chad M. Stiening on January 14, 2011 and is headquartered in St. Louis, MO. | Health Services |
Biosensia Ltd.
Biosensia Ltd. Packaged SoftwareTechnology Services Biosensia Ltd. develops multiplexing point of care in vitro diagnostics platform. It offers RapiPlex, a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results. The company was founded by Gareth Redmond and Gabriel Crean in 2009 and is headquartered in Dublin, Ireland. | Technology Services |
Alverix, Inc.
 Alverix, Inc. Medical SpecialtiesHealth Technology Alverix, Inc. manufactures diagnostic devices. It produces devices using reflectance and gated fluorescent detection. The firm also offers optical sensors, image processing, and signal enhancement algorithms. The company was founded in 2007 and is headquartered in San Jose, CA. | Health Technology |
Abram Scientific, Inc.
Abram Scientific, Inc. Medical SpecialtiesHealth Technology Abram Scientific, Inc. manufactures medical diagnostic devices. The private company is based in Menlo Park, CA. The company was founded by Abhishek Ramkumar. Edward F. Brennan has been the CEO of the company since 2015. | Health Technology |
| Cardiac Designs, Inc. | |
Geneoscopy, Inc.
Geneoscopy, Inc. Miscellaneous Commercial ServicesCommercial Services Geneoscopy LLC develops diagnostics It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. The firm provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. The company was founded by Andrew Barnell, Erica Barnell and Yiming Kang in 2015 and is headquartered in Saint Louis, MO. | Commercial Services |
Synchrony Bio, LLC
Synchrony Bio, LLC Financial ConglomeratesFinance Synchrony Bio LLC is a biomedical and life science venture capital firm that aims to achieve superior investor returns in early-stage ventures. The private company is based in St. Louis. The American company aligns seasoned talent, staged investment capital, and process efficiencies to overcome unique challenges faced by medical device and diagnostics ventures, in order to realize significant upside and superior returns. Synchrony Bio's extended network of experts and advisors includes professionals with deep, cross-functional experience and backgrounds. The company was founded by James D. Merselis. | Finance |
- Stock Market
- Insiders
- James Merselis
